Clinical Trials Sponsored by kejiang Cao

Total 16903 results

Zhejiang Cancer Hospital

Recruiting

Single Cell Sequencing Analysis of Thymoma

Thymoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC (R-helper)

Unresectable Stage III NSCLC
Zhejiang Cancer Hospital

Recruiting

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (Neo-DRATEC)

Surgery | Esophageal Carcinoma | Neoadjuvant Chemoradiotherapy

China
Zhejiang Cancer Hospital

Recruiting

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

Neoplasm Metastasis | Nasopharyngeal Cancer

China
Zhejiang Cancer Hospital

Completed

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Active, not recruiting

Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. (NSCLC)

Non-small Cell Lung Cancer | PDL1 Gene Mutation

China
Zhejiang Cancer Hospital

Completed

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Pathological Conditions, Signs and Symptoms

China
Zhejiang Cancer Hospital

Completed

The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy (HFNO)

Hypoxia

China
Zhejiang Cancer Hospital

Active, not recruiting

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

Gastric Cancer | Diagnosis | Multi-omics

China
Zhejiang Cancer Hospital

Active, not recruiting

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Lung Cancer, Small Cell

China
Zhejiang Cancer Hospital

Completed

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Glioblastoma

China
Zhejiang Cancer Hospital

Active, not recruiting

Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics

Gastric Cancer | Signet Ring Cell Carcinoma

China
Zhejiang Cancer Hospital

Completed

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Endobronchial Metastases | Bronchoesophageal Fistula | General Anesthetic Drug Adverse Reaction

China
Zhejiang Cancer Hospital

Completed

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Breast Cancer | HER2 | Preoperative Systemic Treatment
Zhejiang Cancer Hospital

Unknown

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Carcinoma, Hepatocellular
Zhejiang Cancer Hospital

Unknown

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Cervical Cancer

China
Zhejiang Cancer Hospital

Unknown

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma

China
Zhejiang Cancer Hospital

Unknown

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Breast Cancer | Breast Diseases | Neoplasm, Breast

China
Zhejiang Cancer Hospital

Unknown

Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer

Rectal Neoplasms | Neoadjuvant Therapy | Circulating Tumor DNA

China
Zhejiang Cancer Hospital

Unknown

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Unknown

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer (PECP)

Breast Cancer | Breast Neoplasms | Breast Diseases
Zhejiang Cancer Hospital

Unknown

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Completed

Remifemin Preventing the Climacteric Symptoms in Breast Cancer

Safety Issues | Effect of Drugs

China
Zhejiang Cancer Hospital

Unknown

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis

Cerebral Radiation Necrosis

China
Zhejiang Cancer Hospital

Unknown

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

China
Zhejiang Cancer Hospital

Unknown

D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer

Gastric Cancer

China
Zhejiang Cancer Hospital

Unknown

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

Drug Safety | Surgically-Created Resection Cavity

China
Zhejiang Cancer Hospital

Completed

S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Completed

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Completed

Zoladex Plus Tamoxifen in Breast Cancer

Ultrasonography | Lipemia | Endometrium | Mammography | Estrogen

China
Zhejiang Cancer Hospital

Unknown

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Non-small Cell Lung Cancer

China
Shanghai Bao Pharmaceuticals Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults

Healthy

New Zealand
CAS Lamvac Biotech Co., Ltd.

Recruiting

Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumor

China
CAS Lamvac Biotech Co., Ltd.

Recruiting

Plasmodium Immunotherapy for Breast and Liver Cancers

Advanced Breast Cancer | Advanced Liver Cancer

China
CAS Lamvac Biotech Co., Ltd.

Recruiting

Plasmodium Immunotherapy for Advanced Cancers

Advanced Cancers

China
CAO Group, Inc.

Completed

Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction

Abdominal Subcutaneous Fat

United States
kejiang Cao
Third Military Medical University; Chinese Academy of Medical Sciences, Fuwai...

Unknown

Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions (SS-SBVPT)

Premature Ventricular Contraction

China
Zhejiang University
New Horizon Health Technology Co., Ltd; Beijing Mingze Technology Co., Ltd.

Completed

Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China (CLEAR-C)

Colorectal Cancer | Adenoma | Adenomatous Polyps | Advanced Adenoma

China
Zhejiang Biostar Biotechnology Co.
First Affiliated Hospital of Zhejiang University; Guangdong Provincial People... and other collaborators

Enrolling by invitation

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Membranous Nephropathy - PLA2R Induced | Kidney Diseases-except Membranous Nephropathy

China
Zhejiang University
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Study on Serum Metabolomics of GDM

Diagnosis | Pathogenesis | GDM

China
Weijia Fang, MD
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Renal Cell Carcinoma | Ovarian Cancer | Cervix Cancer | Advanced Solid Tumor | Metastatic Tumor

China
Weijia Fang, MD
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Stomach Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Recurrent Cancer | Metastatic Tumor

China
First Affiliated Hospital of Zhejiang University
BeiGene (Beijing) Co., Ltd

Recruiting

TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC

BCLC Stage C Hepatocellular Carcinoma

China
Weijia Fang, MD
Innovative Cellular Therapeutics Co., Ltd.

Completed

CART Therapy in GUCY2C-positive Digestive Tract Tumors (CART)

Malignant Neoplasms of Digestive Organs

China
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China
First Affiliated Hospital of Zhejiang University
CARsgen Therapeutics Co., Ltd.

Active, not recruiting

Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

Refractory or Relapsed Multiple Myeloma

China

Clinical Trials Sponsored by kejiang Cao

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations